You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,648,379


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,648,379
Title: Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
Abstract:Derivatives and analogues of 2-deoxy-2,3-didehydro-N-acetyl neuraminic acid, pharmaceutical formulations thereof, methods for their preparation and their use in the treatment of viral infections, in particular influenza, are described.
Inventor(s): Von Itzstein; Laurence Mark (North Fitzroy, AU), Wu; Wen-Yang (Mount Waverley, AU), Van Phan; Tho (Carnegie, AU), Danylec; Basil (Box Hill, AU), Jin; Betty (Mount Waverly, AU), Colman; Peter Malcolm (East Melbourne, AU), Varghese; Joseph Noozhumurry (Brunswick, AU)
Assignee: Biota Scientific Management Pty., Ltd. (Melbourne, AU)
Application Number:08/325,074
Patent Claim Types:
see list of patent claims
Compound; Composition; Formulation; Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 5,648,379

Introduction

United States Patent 5,648,379, titled "Derivatives and analogues of 2-deoxy-2,3-didehydro-N-acylneuraminic acids," is a patent that pertains to a new class of chemical compounds and their medical applications. This article will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background of the Patent

The patent, granted on July 15, 1997, involves the development of new 4-substituted-2-deoxy-2,3-didehydro-N-acylneuraminic acids, which are derivatives and analogues of sialic acids. These compounds have potential applications in medicine, particularly in the treatment of viral infections and other diseases where sialic acid derivatives play a crucial role[2].

Scope of the Patent

The scope of the patent is defined by the claims, which outline the specific inventions and their applications that are protected.

Claims Analysis

The patent includes multiple claims that describe the chemical structure, synthesis, and uses of the derivatives and analogues.

  • Independent Claims: These claims define the broadest scope of the invention. For example, Claim 1 might describe the general chemical structure of the 4-substituted-2-deoxy-2,3-didehydro-N-acylneuraminic acids.
  • Dependent Claims: These claims narrow down the scope by specifying particular substitutions, synthesis methods, or specific medical uses. For instance, a dependent claim might describe a specific derivative with a particular substituent and its use in treating a specific viral infection[2].

Patent Claims and Scope Measurements

To understand the scope of the patent, it is helpful to refer to the Patent Claims Research Dataset provided by the USPTO. This dataset contains detailed information on claims from U.S. patents, including claim-level statistics and document-level statistics. While this dataset does not specifically include data from 1997, it provides a framework for analyzing patent scope and claims in general. The dataset includes measures such as the number of claims, claim dependencies, and the breadth of the claims, which can help in assessing the overall scope of a patent[3].

Patent Landscape

International Patent Protection

The patent landscape for U.S. Patent 5,648,379 also involves international protection. To determine if similar patents exist abroad, one would need to search international patent databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO)[1][4].

  • European Patent Office (EPO): The EPO's esp@cenet database allows for full-text searching of European patents and provides machine translations for some languages.
  • Japan Patent Office (JPO): Similar to the EPO, the JPO provides access to Japanese patents with machine translations.
  • World Intellectual Property Organization (WIPO): The PATENTSCOPE database offers full-text search capabilities for international Patent Cooperation Treaty (PCT) applications and patent documents from participating national and regional patent offices[1][4].

Related Patents and Prior Art

To fully understand the patent landscape, it is crucial to identify related patents and prior art. Tools like the Common Citation Document (CCD) and the Global Dossier can be used to consolidate citation data and view the patent family for a specific application, including related applications filed at participating IP offices[1].

  • Common Citation Document (CCD): This tool provides a single point of access to up-to-date citation data relating to the patent applications of the IP5 Offices, helping to visualize search results for the same invention produced by several offices on a single page.
  • Global Dossier: This service allows users to see the patent family for a specific application, including all related applications filed at participating IP offices, along with dossier, classification, and citation data[1].

Expiration and Generic Entry

Patent 5,648,379 has expired, as patents typically have a term of 20 years from the filing date. The expiration of the patent allows for generic entry into the market, where other companies can produce and sell the same or similar compounds without infringing on the original patent[5].

Practical Implications

Understanding the scope and claims of U.S. Patent 5,648,379 is crucial for several reasons:

  • Research and Development: Researchers and developers need to ensure that their work does not infringe on existing patents. Analyzing the claims and scope helps in identifying potential areas for innovation that are not already protected.
  • Commercialization: Companies looking to commercialize similar compounds must navigate the patent landscape to avoid infringement and to identify opportunities for generic entry or licensing agreements.

Key Takeaways

  • Patent Scope: The scope of U.S. Patent 5,648,379 is defined by its claims, which describe the chemical structure, synthesis, and medical applications of the derivatives and analogues.
  • International Protection: The patent landscape includes international protection, which can be analyzed using databases from various international patent offices.
  • Expiration and Generic Entry: The patent has expired, allowing for generic entry into the market.
  • Practical Implications: Understanding the patent's scope and claims is essential for research, development, and commercialization.

FAQs

What is the main subject of U.S. Patent 5,648,379?

The main subject of U.S. Patent 5,648,379 is the development of new 4-substituted-2-deoxy-2,3-didehydro-N-acylneuraminic acids and their medical applications.

How can I search for related international patents?

You can search for related international patents using databases such as the European Patent Office's esp@cenet, the Japan Patent Office's database, and the World Intellectual Property Organization's PATENTSCOPE database.

What is the Common Citation Document (CCD)?

The Common Citation Document (CCD) is a tool that provides a single point of access to up-to-date citation data relating to the patent applications of the IP5 Offices, helping to visualize search results for the same invention produced by several offices on a single page.

Has U.S. Patent 5,648,379 expired?

Yes, U.S. Patent 5,648,379 has expired, as patents typically have a term of 20 years from the filing date.

What are the implications of the patent's expiration?

The expiration of the patent allows for generic entry into the market, where other companies can produce and sell the same or similar compounds without infringing on the original patent.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. US5648379A - Derivatives and analogues of 2-deoxy-2,3-didehydro ...: https://patents.google.com/patent/US5648379A/en
  3. Patent Claims Research Dataset - USPTO: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Clemson University - Advanced Patent Searching: https://clemson.libguides.com/advanced_patent_searching
  5. DrugPatentWatch - Patent 5648379: https://www.drugpatentwatch.com/p/patent/5648379

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,648,379

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,648,379

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
AustraliaPJ 9800Apr 24, 1990
AustraliaPK 2896Oct 19, 1990
AustraliaPK 4537Feb 11, 1991

International Family Members for US Patent 5,648,379

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0526543 ⤷  Subscribe C990030 Netherlands ⤷  Subscribe
European Patent Office 0526543 ⤷  Subscribe SPC/GB99/030 United Kingdom ⤷  Subscribe
European Patent Office 0526543 ⤷  Subscribe 990030 Netherlands ⤷  Subscribe
European Patent Office 0526543 ⤷  Subscribe 99C0042 Belgium ⤷  Subscribe
European Patent Office 0526543 ⤷  Subscribe 34/1999 Austria ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.